Sulfone [EPC]

Sulfone [EPC] was reported 10881 times

These side effects are most commonly reported by patients taking drugs of the Sulfone [EPC] class:

# Drug class Count
0 OFF LABEL USE 1307
1 DRUG INEFFECTIVE 1167
2 METHAEMOGLOBINAEMIA 499
3 NAUSEA 492
4 FATIGUE 490
5 PYREXIA 474
6 DIARRHOEA 427
7 RASH 407
8 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 399
9 DYSPNOEA 394
10 PNEUMONIA 385
11 PAIN 377
12 ANAEMIA 376
13 CONDITION AGGRAVATED 367
14 TREATMENT FAILURE 364
15 PRODUCT USE IN UNAPPROVED INDICATION 351
16 HEADACHE 308
17 VOMITING 293
18 ASTHENIA 291
19 ACUTE KIDNEY INJURY 245
20 DEATH 242
21 PRURITUS 242
22 SEPSIS 236
23 RENAL FAILURE 233
24 DIZZINESS 225
25 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 212
26 ANXIETY 206
27 DRUG INTERACTION 198
28 THROMBOCYTOPENIA 197
29 HYPERTENSION 195
30 ERYTHEMA 192
31 MALAISE 192
32 WEIGHT DECREASED 185
33 ABDOMINAL PAIN 179
34 HYPOTENSION 178
35 COUGH 176
36 NEUTROPENIA 173
37 HAEMOLYTIC ANAEMIA 172
38 URTICARIA 170
39 ARTHRALGIA 168
40 PRODUCT DOSE OMISSION ISSUE 166
41 PANCYTOPENIA 163
42 DRUG HYPERSENSITIVITY 159
43 DEPRESSION 158
44 EMOTIONAL DISTRESS 156
45 WEIGHT INCREASED 154
46 DECREASED APPETITE 142
47 CHRONIC KIDNEY DISEASE 140
48 HYPOXIA 138
49 PLATELET COUNT DECREASED 138
50 BLOOD CREATININE INCREASED 137
51 CONSTIPATION 137
52 FALL 136
53 RENAL IMPAIRMENT 136
54 HAEMOGLOBIN DECREASED 131
55 WHITE BLOOD CELL COUNT DECREASED 130
56 THERAPY NON-RESPONDER 129
57 DRUG INTOLERANCE 126
58 FEBRILE NEUTROPENIA 126
59 OEDEMA PERIPHERAL 125
60 DISEASE PROGRESSION 124
61 INFECTION 122
62 NEUROPATHY PERIPHERAL 122
63 SKIN EXFOLIATION 122
64 RESPIRATORY FAILURE 121
65 INTENTIONAL PRODUCT USE ISSUE 119
66 BACK PAIN 118
67 OXYGEN SATURATION DECREASED 116
68 DEHYDRATION 114
69 INSOMNIA 113
70 CHEST PAIN 112
71 CHILLS 111
72 CONFUSIONAL STATE 111
73 NO ADVERSE EVENT 111
74 ANGIOEDEMA 107
75 BLOOD PRESSURE INCREASED 107
76 FEELING ABNORMAL 107
77 ANHEDONIA 106
78 ACNE 105
79 MUSCLE SPASMS 105
80 HYPERSENSITIVITY 104
81 PRODUCT USE ISSUE 104
82 URINARY TRACT INFECTION 103
83 DRUG-INDUCED LIVER INJURY 102
84 LEUKOPENIA 99
85 PAIN IN EXTREMITY 98
86 PULMONARY EMBOLISM 96
87 DISEASE RECURRENCE 95
88 MYALGIA 95
89 PERIPHERAL SWELLING 92
90 GAIT DISTURBANCE 91
91 OSTEOPOROSIS 88
92 BLISTER 87
93 COVID-19 86
94 DEEP VEIN THROMBOSIS 86
95 HAEMOLYSIS 85
96 TOXICITY TO VARIOUS AGENTS 84
97 DRY SKIN 82
98 TREMOR 80
99 CATARACT 77
100 MUSCULAR WEAKNESS 77
101 ADVERSE DRUG REACTION 76
102 ALOPECIA 76
103 CELLULITIS 76
104 SKIN LESION 76
105 VISION BLURRED 76
106 HYPOAESTHESIA 75
107 RENAL FAILURE ACUTE 75
108 ABDOMINAL DISCOMFORT 74
109 NASOPHARYNGITIS 74
110 SINUSITIS 74
111 CYTOMEGALOVIRUS INFECTION 73
112 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 73
113 LETHARGY 73
114 PLEURAL EFFUSION 73
115 SOMNOLENCE 73
116 PARAESTHESIA 72
117 GENERAL PHYSICAL HEALTH DETERIORATION 71
118 HOSPITALISATION 71
119 TACHYCARDIA 71
120 GASTROINTESTINAL DISORDER 70
121 PRODUCT QUALITY ISSUE 70
122 REBOUND EFFECT 70
123 STAPHYLOCOCCAL INFECTION 70
124 UPPER RESPIRATORY TRACT INFECTION 70
125 ABDOMINAL PAIN UPPER 69
126 ASPARTATE AMINOTRANSFERASE INCREASED 67
127 RASH ERYTHEMATOUS 67
128 END STAGE RENAL DISEASE 65
129 INFLUENZA 65
130 PEMPHIGOID 65
131 ALANINE AMINOTRANSFERASE INCREASED 64
132 ECONOMIC PROBLEM 63
133 LINEAR IGA DISEASE 63
134 RASH MACULO-PAPULAR 63
135 SEPTIC SHOCK 62
136 THERAPY PARTIAL RESPONDER 62
137 DIABETES MELLITUS 61
138 OSTEONECROSIS 61
139 RASH PRURITIC 61
140 SKIN DISCOLOURATION 61
141 JAUNDICE 60
142 LYMPHADENOPATHY 60
143 TREATMENT NONCOMPLIANCE 60
144 ATRIAL FIBRILLATION 59
145 BONE MARROW FAILURE 59
146 BRONCHITIS 59
147 PALPITATIONS 59
148 PLASMA CELL MYELOMA 59
149 PRODUCT DELIVERY MECHANISM ISSUE 59
150 HIDRADENITIS 58
151 ASTHMA 57
152 BLOOD GLUCOSE INCREASED 57
153 CONTUSION 57
154 LOSS OF CONSCIOUSNESS 57
155 SWELLING 57
156 MENTAL DISORDER 56
157 MOBILITY DECREASED 56
158 THROMBOSIS 56
159 ACUTE RESPIRATORY FAILURE 55
160 HERPES ZOSTER 55
161 THERAPEUTIC RESPONSE DECREASED 55
162 CYANOSIS 54
163 DRUG DOSE OMISSION 54
164 PYODERMA GANGRENOSUM 54
165 BURNING SENSATION 53
166 CEREBROVASCULAR ACCIDENT 53
167 DYSPHAGIA 53
168 BLOOD BILIRUBIN INCREASED 52
169 GASTROOESOPHAGEAL REFLUX DISEASE 52
170 HYPERKALAEMIA 52
171 MENTAL STATUS CHANGES 52
172 SWELLING FACE 52
173 PNEUMOCYSTIS JIROVECII PNEUMONIA 51
174 PSEUDOMONAS INFECTION 51
175 HEPATIC ENZYME INCREASED 50
176 OSTEOPENIA 50
177 RED BLOOD CELL COUNT DECREASED 50
178 SKIN DISORDER 50
179 ABDOMINAL DISTENSION 49
180 CARDIAC FAILURE 49
181 GRAFT VERSUS HOST DISEASE 49
182 HEPATITIS 49
183 OEDEMA 49
184 SUICIDAL IDEATION 49
185 TYPE 2 LEPRA REACTION 49
186 INJECTION SITE REACTION 48
187 MYOCARDIAL INFARCTION 48
188 SKIN IRRITATION 48
189 SYNCOPE 48
190 CLOSTRIDIUM DIFFICILE INFECTION 47
191 SEROTONIN SYNDROME 47
192 BLOOD PRESSURE SYSTOLIC INCREASED 46
193 DRUG RESISTANCE 46
194 HEPATIC FAILURE 46
195 LEUKOCYTOSIS 46
196 MEMORY IMPAIRMENT 46
197 NEUTROPHIL COUNT DECREASED 46
198 VISUAL IMPAIRMENT 46
199 WHITE BLOOD CELL COUNT INCREASED 46
200 ANAPHYLACTIC REACTION 45
201 DERMATITIS 45
202 HAEMORRHAGE 45
203 LIVER FUNCTION TEST ABNORMAL 45
204 PRODUCTIVE COUGH 45
205 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 45
206 CARDIAC ARREST 44
207 HEART RATE INCREASED 44
208 ILLNESS 44
209 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 44
210 GASTROINTESTINAL HAEMORRHAGE 43
211 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 43
212 INTENTIONAL OVERDOSE 43
213 MULTIPLE ORGAN DYSFUNCTION SYNDROME 43
214 MYOPATHY 43
215 STEVENS-JOHNSON SYNDROME 43
216 HYDRONEPHROSIS 42
217 HYPERGLYCAEMIA 42
218 LUNG DISORDER 42
219 OROPHARYNGEAL PAIN 42
220 SYSTEMIC LUPUS ERYTHEMATOSUS 42
221 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 41
222 FUNGAL INFECTION 41
223 JOINT SWELLING 41
224 METABOLIC ACIDOSIS 41
225 RASH MACULAR 41
226 RESPIRATORY DISTRESS 41
227 STRESS 41
228 ULCER 41
229 DELIRIUM 40
230 LUNG INFILTRATION 40
231 SKIN ULCER 40
232 AMNESIA 39
233 BLOOD ALKALINE PHOSPHATASE INCREASED 39
234 CUSHINGOID 39
235 DYSPNOEA EXERTIONAL 39
236 HYPERHIDROSIS 39
237 INFUSION RELATED REACTION 39
238 INJECTION SITE PAIN 39
239 NOCARDIOSIS 39
240 TYPE 1 DIABETES MELLITUS 39
241 IMPAIRED HEALING 38
242 MUSCULOSKELETAL STIFFNESS 38
243 BALANCE DISORDER 37
244 CHEST DISCOMFORT 37
245 EPISTAXIS 37
246 HYPONATRAEMIA 37
247 LABORATORY TEST ABNORMAL 37
248 MIGRAINE 37
249 NIGHT SWEATS 37
250 ORAL CANDIDIASIS 37
251 PNEUMONITIS 37
252 SKIN BURNING SENSATION 37
253 CLOSTRIDIUM DIFFICILE COLITIS 36
254 ENCEPHALOPATHY 36
255 INCORRECT DOSE ADMINISTERED 36
256 INFLUENZA LIKE ILLNESS 36
257 PANCREATITIS 36
258 PRODUCT SUBSTITUTION ISSUE 36
259 PULMONARY OEDEMA 36
260 RENAL DISORDER 36
261 BLOOD PRESSURE DECREASED 35
262 BONE DENSITY DECREASED 35
263 CARDIAC FAILURE CONGESTIVE 35
264 CHRONIC SPONTANEOUS URTICARIA 35
265 CYTOKINE RELEASE SYNDROME 35
266 CYTOMEGALOVIRUS VIRAEMIA 35
267 FLUSHING 35
268 HAEMATOCRIT DECREASED 35
269 PSORIASIS 35
270 RENAL TUBULAR NECROSIS 35
271 SEIZURE 35
272 UNEVALUABLE EVENT 35
273 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35
274 ABSCESS 34
275 AGRANULOCYTOSIS 34
276 APPLICATION SITE PAIN 34
277 BLOOD LACTATE DEHYDROGENASE INCREASED 34
278 CONVULSION 34
279 MYCOBACTERIUM AVIUM COMPLEX INFECTION 34
280 SCAR 34
281 BASAL CELL CARCINOMA 33
282 KLEBSIELLA INFECTION 33
283 PRODUCT PHYSICAL CONSISTENCY ISSUE 33
284 RHEUMATOID ARTHRITIS 33
285 TOXIC EPIDERMAL NECROLYSIS 33
286 ACUTE RESPIRATORY DISTRESS SYNDROME 32
287 DRUG ERUPTION 32
288 DYSPEPSIA 32
289 HAEMATURIA 32
290 INJECTION SITE ERYTHEMA 32
291 INTENTIONAL PRODUCT MISUSE 32
292 LIVER DISORDER 32
293 PHOTOPHOBIA 32
294 BRONCHOPULMONARY ASPERGILLOSIS 31
295 DEPRESSED LEVEL OF CONSCIOUSNESS 31
296 DIVERTICULITIS 31
297 DRY EYE 31
298 MUCOSAL INFLAMMATION 31
299 PHOTOSENSITIVITY REACTION 31
300 RASH PAPULAR 31
301 SLEEP DISORDER 31
302 THERAPEUTIC RESPONSE UNEXPECTED 31
303 C-REACTIVE PROTEIN INCREASED 30
304 EPSTEIN-BARR VIRUS INFECTION 30
305 HYPOKALAEMIA 30
306 ILL-DEFINED DISORDER 30
307 NECROTISING FASCIITIS 30
308 OVERDOSE 30
309 PEMPHIGUS 30
310 QUALITY OF LIFE DECREASED 30
311 STOMATITIS 30
312 VIRAL INFECTION 30
313 BLOOD PRESSURE FLUCTUATION 29
314 FEELING HOT 29
315 HAEMATOCHEZIA 29
316 HEPATOTOXICITY 29
317 HYPERBILIRUBINAEMIA 29
318 LOWER RESPIRATORY TRACT INFECTION 29
319 MENINGITIS ASEPTIC 29
320 RECTAL HAEMORRHAGE 29
321 WHEEZING 29
322 ARTHRITIS 28
323 CARDIAC DISORDER 28
324 CROHN^S DISEASE 28
325 FULL BLOOD COUNT DECREASED 28
326 LIP SWELLING 28
327 NASAL CONGESTION 28
328 NODULE 28
329 PAIN OF SKIN 28
330 SKIN HYPERPIGMENTATION 28
331 VANISHING BILE DUCT SYNDROME 28
332 APPLICATION SITE ERYTHEMA 27
333 BLOOD UREA INCREASED 27
334 CHOLESTASIS 27
335 EOSINOPHILIA 27
336 FLUID RETENTION 27
337 INTERNATIONAL NORMALISED RATIO INCREASED 27
338 INTERSTITIAL LUNG DISEASE 27
339 MULTI-ORGAN FAILURE 27
340 RESPIRATORY DISORDER 27
341 SUICIDE ATTEMPT 27
342 BRAIN ABSCESS 26
343 COLITIS 26
344 CYST 26
345 DYSGEUSIA 26
346 ECZEMA 26
347 ESCHERICHIA INFECTION 26
348 EXPOSURE DURING PREGNANCY 26
349 EYE SWELLING 26
350 LUPUS-LIKE SYNDROME 26
351 PRODUCT DOSE OMISSION 26
352 PRODUCT PRESCRIBING ISSUE 26
353 ASCITES 25
354 BACTERIAL INFECTION 25
355 BLINDNESS 25
356 BLOOD POTASSIUM DECREASED 25
357 CARPAL TUNNEL SYNDROME 25
358 DRY MOUTH 25
359 HEPATOMEGALY 25
360 HIP FRACTURE 25
361 HYPOGLYCAEMIA 25
362 INFLAMMATION 25
363 INJECTION SITE SWELLING 25
364 OCULAR HYPERAEMIA 25
365 PERICARDIAL EFFUSION 25
366 STAPHYLOCOCCAL BACTERAEMIA 25
367 TRANSAMINASES INCREASED 25
368 WOUND 25
369 ADVERSE EVENT 24
370 BACTERAEMIA 24
371 DISORIENTATION 24
372 DYSURIA 24
373 FOETAL EXPOSURE DURING PREGNANCY 24
374 GLUCOSE TOLERANCE IMPAIRED 24
375 HEPATIC FUNCTION ABNORMAL 24
376 HYPOTHYROIDISM 24
377 NEPHROLITHIASIS 24
378 PRODUCT PHYSICAL ISSUE 24
379 PROTEINURIA 24
380 VASCULITIS 24
381 AGITATION 23
382 APHASIA 23
383 ASPERGILLUS INFECTION 23
384 BEHCET^S SYNDROME 23
385 BLOOD CHOLESTEROL INCREASED 23
386 DEPRESSED MOOD 23
387 DRUG DEPENDENCE 23
388 FLATULENCE 23
389 GASTRITIS 23
390 IMMUNE RECONSTITUTION SYNDROME 23
391 INJECTION SITE BRUISING 23
392 LYMPHADENITIS 23
393 LYMPHOPENIA 23
394 MOUTH ULCERATION 23
395 OSTEOARTHRITIS 23
396 PAPULE 23
397 PULMONARY HYPERTENSION 23
398 RENAL INJURY 23
399 SKIN PLAQUE 23
400 SUBCUTANEOUS ABSCESS 23
401 THROMBOTIC MICROANGIOPATHY 23
402 UROSEPSIS 23
403 WOUND COMPLICATION 23
404 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 22
405 ACUTE MYELOID LEUKAEMIA 22
406 ADRENAL INSUFFICIENCY 22
407 BLOOD ALBUMIN DECREASED 22
408 BONE PAIN 22
409 COELIAC DISEASE 22
410 COMA 22
411 DERMATITIS ATOPIC 22
412 DRUG TOXICITY 22
413 EYE IRRITATION 22
414 GINGIVAL BLEEDING 22
415 HAEMODIALYSIS 22
416 HYPOVOLAEMIA 22
417 IMMUNODEFICIENCY 22
418 LIVER INJURY 22
419 MUSCULOSKELETAL PAIN 22
420 PNEUMOTHORAX 22
421 SKIN ODOUR ABNORMAL 22
422 THERAPY INTERRUPTED 22
423 WOUND SECRETION 22
424 ARTHROPATHY 21
425 COGNITIVE DISORDER 21
426 DERMATITIS BULLOUS 21
427 KIDNEY TRANSPLANT REJECTION 21
428 NEUTROPENIC SEPSIS 21
429 PETECHIAE 21
430 PNEUMONIA PSEUDOMONAL 21
431 RASH GENERALISED 21
432 TACHYPNOEA 21
433 BLOOD METHAEMOGLOBIN PRESENT 20
434 BLOOD POTASSIUM INCREASED 20
435 DYSPHONIA 20
436 ENCEPHALITIS 20
437 INJURY 20
438 LOCALISED INFECTION 20
439 LUPUS NEPHRITIS 20
440 MALIGNANT NEOPLASM PROGRESSION 20
441 MENTAL IMPAIRMENT 20
442 PULMONARY MASS 20
443 RHINORRHOEA 20
444 SINUS DISORDER 20
445 AUTOIMMUNE HAEMOLYTIC ANAEMIA 19
446 BRADYCARDIA 19
447 COAGULOPATHY 19
448 CYSTITIS 19
449 DECREASED ACTIVITY 19
450 DISCOMFORT 19
451 DISTURBANCE IN ATTENTION 19
452 DRUG EFFECT INCOMPLETE 19
453 DRUG EXPOSURE DURING PREGNANCY 19
454 FLUID OVERLOAD 19
455 GLAUCOMA 19
456 LYMPHOMA 19
457 MATERNAL EXPOSURE DURING PREGNANCY 19
458 NECK PAIN 19
459 PLATELET COUNT ABNORMAL 19
460 SHOCK 19
461 STILL^S DISEASE 19
462 THROAT IRRITATION 19
463 APHTHOUS ULCER 18
464 APPLICATION SITE DISCOLOURATION 18
465 CARDIO-RESPIRATORY ARREST 18
466 DERMATITIS EXFOLIATIVE 18
467 ENTEROCOCCAL INFECTION 18
468 EYE PAIN 18
469 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 18
470 HEART RATE DECREASED 18
471 LACTIC ACIDOSIS 18
472 LIMB INJURY 18
473 LYMPHOCYTE COUNT DECREASED 18
474 NERVOUSNESS 18
475 NEURALGIA 18
476 OBESITY 18
477 OSTEOMYELITIS 18
478 PANCREATITIS ACUTE 18
479 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 18
480 SPEECH DISORDER 18
481 SQUAMOUS CELL CARCINOMA 18
482 SURGERY 18
483 TASTE DISORDER 18
484 THERAPEUTIC PRODUCT INEFFECTIVE 18
485 TYPE 2 DIABETES MELLITUS 18
486 VERTIGO 18
487 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 17
488 CHEILITIS 17
489 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17
490 CORONARY ARTERY DISEASE 17
491 COVID-19 PNEUMONIA 17
492 CYTOMEGALOVIRUS TEST POSITIVE 17
493 CYTOPENIA 17
494 DYSARTHRIA 17
495 EAR INFECTION 17
496 ERYTHEMA MULTIFORME 17
497 GASTRIC DISORDER 17
498 GRANULOMA 17
499 HALLUCINATION 17
500 HEPATITIS FULMINANT 17
501 HYPOCALCAEMIA 17
502 IMMUNE THROMBOCYTOPENIA 17
503 INTERVERTEBRAL DISC DEGENERATION 17
504 KIDNEY INFECTION 17
505 MOOD SWINGS 17
506 MYELOSUPPRESSION 17
507 NEPHROGENIC ANAEMIA 17
508 POLLAKIURIA 17
509 PRE-EXISTING CONDITION IMPROVED 17
510 PULMONARY FIBROSIS 17
511 PULMONARY HAEMORRHAGE 17
512 SCRATCH 17
513 SMALL INTESTINAL OBSTRUCTION 17
514 SPINAL FRACTURE 17
515 SPLENOMEGALY 17
516 TINNITUS 17
517 TRANSPLANT REJECTION 17
518 TUBULOINTERSTITIAL NEPHRITIS 17
519 TYPE 1 LEPRA REACTION 17
520 ACUTE HEPATIC FAILURE 16
521 AGGRESSION 16
522 APLASIA PURE RED CELL 16
523 BLOOD IRON DECREASED 16
524 CANDIDA INFECTION 16
525 COLITIS ULCERATIVE 16
526 DIPLOPIA 16
527 DYSSTASIA 16
528 EYELID IRRITATION 16
529 GAIT INABILITY 16
530 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16
531 GASTROENTERITIS 16
532 HEPATITIS B 16
533 HERPES SIMPLEX 16
534 HYPERLIPIDAEMIA 16
535 NECROSIS 16
536 PRESYNCOPE 16
537 PRODUCT CONTAINER ISSUE 16
538 PSYCHOTIC DISORDER 16
539 RESPIRATORY TRACT INFECTION 16
540 SKIN INFECTION 16
541 ABORTION SPONTANEOUS 15
542 ANOREXIA 15
543 APPLICATION SITE IRRITATION 15
544 BLOOD PRESSURE SYSTOLIC ABNORMAL 15
545 BLOOD SODIUM DECREASED 15
546 BLOOD TRIGLYCERIDES INCREASED 15
547 CEREBRAL HAEMORRHAGE 15
548 CHOLELITHIASIS 15
549 CUTANEOUS LUPUS ERYTHEMATOSUS 15
550 DIALYSIS 15
551 FACE OEDEMA 15
552 FACIAL PAIN 15
553 HYPOMAGNESAEMIA 15
554 HYPOPHAGIA 15
555 IMPAIRED WORK ABILITY 15
556 IRRITABLE BOWEL SYNDROME 15
557 LEPROMATOUS LEPROSY 15
558 LUNG INFECTION 15
559 MEDICATION ERROR 15
560 NEOPLASM MALIGNANT 15
561 PALLOR 15
562 PLEOCYTOSIS 15
563 RHABDOMYOLYSIS 15
564 SQUAMOUS CELL CARCINOMA OF SKIN 15
565 SUPRAVENTRICULAR TACHYCARDIA 15
566 SYNOVIAL CYST 15
567 THERAPEUTIC PRODUCT EFFECT DECREASED 15
568 THERAPY CESSATION 15
569 TOXOPLASMOSIS 15
570 UNRESPONSIVE TO STIMULI 15
571 VENTRICULAR TACHYCARDIA 15
572 ACIDOSIS 14
573 ACUTE MYOCARDIAL INFARCTION 14
574 ANAEMIA MACROCYTIC 14
575 ARRHYTHMIA 14
576 ATELECTASIS 14
577 BK VIRUS INFECTION 14
578 BLOOD DISORDER 14
579 BRAIN OEDEMA 14
580 CUSHING^S SYNDROME 14
581 DERMATITIS HERPETIFORMIS 14
582 DIFFUSE LARGE B-CELL LYMPHOMA 14
583 DISSEMINATED INTRAVASCULAR COAGULATION 14
584 FOOT FRACTURE 14
585 GASTRIC ULCER 14
586 HAEMOGLOBIN ABNORMAL 14
587 HAEMOPTYSIS 14
588 HEPATIC CIRRHOSIS 14
589 HYPERCALCAEMIA 14
590 INJECTION SITE PRURITUS 14
591 INSURANCE ISSUE 14
592 LIVER FUNCTION TEST INCREASED 14
593 MALNUTRITION 14
594 MUSCLE ATROPHY 14
595 PARADOXICAL DRUG REACTION 14
596 POOR VENOUS ACCESS 14
597 PRODUCT AVAILABILITY ISSUE 14
598 PRURITUS GENERALISED 14
599 RENAL TRANSPLANT 14
600 SKIN PAPILLOMA 14
601 TORSADE DE POINTES 14
602 URINARY RETENTION 14
603 VISUAL ACUITY REDUCED 14
604 ZYGOMYCOSIS 14
605 ABASIA 13
606 APPLICATION SITE DRYNESS 13
607 AZOTAEMIA 13
608 BODY TEMPERATURE INCREASED 13
609 BONE DISORDER 13
610 BONE LOSS 13
611 CUTANEOUS VASCULITIS 13
612 CYTOMEGALOVIRUS INFECTION REACTIVATION 13
613 DERMATITIS CONTACT 13
614 DIABETES MELLITUS INADEQUATE CONTROL 13
615 DISSEMINATED CRYPTOCOCCOSIS 13
616 EAR DISCOMFORT 13
617 EAR PAIN 13
618 GENERALISED OEDEMA 13
619 IMMUNOSUPPRESSION 13
620 INTENTIONAL DOSE OMISSION 13
621 IRRITABILITY 13
622 MOOD ALTERED 13
623 NEUROTOXICITY 13
624 NIGHTMARE 13
625 ORTHOSTATIC HYPOTENSION 13
626 PANIC ATTACK 13
627 PRODUCT FORMULATION ISSUE 13
628 RESPIRATORY RATE INCREASED 13
629 SKIN NECROSIS 13
630 SLEEP APNOEA SYNDROME 13
631 TENDERNESS 13
632 TOOTH DISORDER 13
633 URINARY INCONTINENCE 13
634 ABDOMINAL PAIN LOWER 12
635 ABNORMAL BEHAVIOUR 12
636 AEROMONAS INFECTION 12
637 AREFLEXIA 12
638 BLINDNESS UNILATERAL 12
639 BLOOD CREATINE PHOSPHOKINASE INCREASED 12
640 BLOOD PRESSURE DIASTOLIC DECREASED 12
641 CD4 LYMPHOCYTES DECREASED 12
642 DERMATITIS ALLERGIC 12
643 DERMATITIS EXFOLIATIVE GENERALISED 12
644 DEVICE RELATED INFECTION 12
645 EMOTIONAL DISORDER 12
646 EXPIRED PRODUCT ADMINISTERED 12
647 EYE PRURITUS 12
648 EYELID PTOSIS 12
649 GASTRIC ULCER HAEMORRHAGE 12
650 GASTROENTERITIS VIRAL 12
651 GROIN PAIN 12
652 HAEMATOMA 12
653 HEPATORENAL SYNDROME 12
654 HYPERSOMNIA 12
655 HYPERTRIGLYCERIDAEMIA 12
656 HYPOACUSIS 12
657 HYPOGAMMAGLOBULINAEMIA 12
658 IMMUNE SYSTEM DISORDER 12
659 LIPASE INCREASED 12
660 LUNG CONSOLIDATION 12
661 LUNG NEOPLASM MALIGNANT 12
662 MASS 12
663 MULTIPLE FRACTURES 12
664 MYELODYSPLASTIC SYNDROME 12
665 NEPHROPATHY TOXIC 12
666 NO THERAPEUTIC RESPONSE 12
667 NOCTURIA 12
668 PNEUMONIA CYTOMEGALOVIRAL 12
669 PNEUMONIA FUNGAL 12
670 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12
671 PRODUCT DOSE OMISSION IN ERROR 12
672 PURULENT DISCHARGE 12
673 PUSTULE 12
674 RENAL CYST 12
675 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12
676 SKIN MASS 12
677 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12
678 SPINAL COMPRESSION FRACTURE 12
679 STEROID DEPENDENCE 12
680 VITAMIN D DEFICIENCY 12
681 ACCIDENTAL EXPOSURE TO PRODUCT 11
682 ACNE CYSTIC 11
683 ADENOVIRUS INFECTION 11
684 ANURIA 11
685 ASPIRATION 11
686 CALCIPHYLAXIS 11
687 CARDIOGENIC SHOCK 11
688 CARDIOMEGALY 11
689 COMPLETED SUICIDE 11
690 CRYING 11
691 DIABETIC KETOACIDOSIS 11
692 DRUG LEVEL ABOVE THERAPEUTIC 11
693 DYSKINESIA 11
694 ECCHYMOSIS 11
695 ESCHERICHIA BACTERAEMIA 11
696 EYE DISORDER 11
697 FAILURE TO THRIVE 11
698 FISTULA 11
699 GENERALISED TONIC-CLONIC SEIZURE 11
700 GLOMERULONEPHRITIS 11
701 HAEMODYNAMIC INSTABILITY 11
702 HOT FLUSH 11
703 HYDROCEPHALUS 11
704 INJECTION SITE URTICARIA 11
705 INTESTINAL OBSTRUCTION 11
706 JARISCH-HERXHEIMER REACTION 11
707 JUGULAR VEIN THROMBOSIS 11
708 LACRIMATION INCREASED 11
709 LEUKAEMOID REACTION 11
710 LEUKOENCEPHALOPATHY 11
711 MYASTHENIA GRAVIS 11
712 OCULAR ICTERUS 11
713 ONYCHOMADESIS 11
714 PARALYSIS 11
715 PLATELET COUNT INCREASED 11
716 PNEUMOMEDIASTINUM 11
717 PNEUMONIA BACTERIAL 11
718 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11
719 RHINOVIRUS INFECTION 11
720 SKIN CANCER 11
721 SKIN SWELLING 11
722 STEM CELL TRANSPLANT 11
723 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 11
724 WHITE BLOOD CELL COUNT ABNORMAL 11
725 ACCIDENTAL POISONING 10
726 ACTIVITIES OF DAILY LIVING IMPAIRED 10
727 ALOPECIA SCARRING 10
728 ANKLE FRACTURE 10
729 AUTOIMMUNE DISORDER 10
730 BLOOD CREATININE ABNORMAL 10
731 BLOOD MAGNESIUM DECREASED 10
732 BONE DEMINERALISATION 10
733 CANDIDIASIS 10
734 CENTRAL OBESITY 10
735 CHROMATURIA 10
736 CYTOMEGALOVIRUS CHORIORETINITIS 10
737 DIZZINESS POSTURAL 10
738 DRUG EFFECT LESS THAN EXPECTED 10
739 EOSINOPHIL COUNT INCREASED 10
740 FANCONI SYNDROME ACQUIRED 10
741 FEAR 10
742 FEMUR FRACTURE 10
743 FIBROMYALGIA 10
744 FOETAL GROWTH RESTRICTION 10
745 FOOT DEFORMITY 10
746 GANGRENE 10
747 HAEMORRHAGE INTRACRANIAL 10
748 HEPATIC NECROSIS 10
749 HERPES VIRUS INFECTION 10
750 HYPOAESTHESIA ORAL 10
751 HYPOPHOSPHATAEMIA 10
752 INFECTION REACTIVATION 10
753 INJECTION SITE HAEMORRHAGE 10
754 INTERVERTEBRAL DISC PROTRUSION 10
755 IRON DEFICIENCY ANAEMIA 10
756 JOINT RANGE OF MOTION DECREASED 10
757 MULTIPLE MYELOMA 10
758 NEOPLASM PROGRESSION 10
759 NEPHRITIS 10
760 NEPHROGENIC SYSTEMIC FIBROSIS 10
761 NERVOUS SYSTEM DISORDER 10
762 OESOPHAGEAL ULCER 10
763 OESOPHAGITIS 10
764 OSTEONECROSIS OF JAW 10
765 POLYARTHRITIS 10
766 POST PROCEDURAL COMPLICATION 10
767 PREGNANCY 10
768 PULMONARY CONGESTION 10
769 PURPURA 10
770 RIB FRACTURE 10
771 ROSACEA 10
772 SARS-COV-2 TEST POSITIVE 10
773 SEBORRHOEA 10
774 SKIN FISSURES 10
775 SKIN INDURATION 10
776 STREPTOCOCCAL INFECTION 10
777 SWOLLEN TONGUE 10
778 THROAT TIGHTNESS 10
779 TOOTHACHE 10
780 UPPER-AIRWAY COUGH SYNDROME 10
781 URTICARIAL VASCULITIS 10
782 VENTRICULAR FIBRILLATION 10
783 ABNORMAL DREAMS 9
784 AGEUSIA 9
785 APLASTIC ANAEMIA 9
786 APPLICATION SITE EXFOLIATION 9
787 APPLICATION SITE PRURITUS 9
788 BACTERIAL SEPSIS 9
789 BIPOLAR DISORDER 9
790 BLOOD COUNT ABNORMAL 9
791 BLOOD CULTURE POSITIVE 9
792 BLOOD GLUCOSE DECREASED 9
793 BLOOD PHOSPHORUS INCREASED 9
794 BRAIN FOG 9
795 BRAIN INJURY 9
796 BREAST CANCER 9
797 CEREBRAL ISCHAEMIA 9
798 CEREBRAL TOXOPLASMOSIS 9
799 CHRONIC GRAFT VERSUS HOST DISEASE 9
800 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9
801 CHRONIC LYMPHOCYTIC LEUKAEMIA 9
802 COMPUTERISED TOMOGRAM THORAX ABNORMAL 9
803 COORDINATION ABNORMAL 9
804 CRYOGLOBULINAEMIA 9
805 CYTOMEGALOVIRUS COLITIS 9
806 DEAFNESS 9
807 DIFFUSE ALVEOLAR DAMAGE 9
808 DISSEMINATED TUBERCULOSIS 9
809 DRUG EFFECT DECREASED 9
810 EYE INFLAMMATION 9
811 HEPATIC STEATOSIS 9
812 HERNIA 9
813 HYPERPARATHYROIDISM SECONDARY 9
814 ILEUS 9
815 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9
816 IMPAIRED GASTRIC EMPTYING 9
817 INDURATION 9
818 INJECTION SITE RASH 9
819 ISCHAEMIC STROKE 9
820 LEPROSY 9
821 LOCAL SWELLING 9
822 LUNG ABSCESS 9
823 LYME DISEASE 9
824 LYMPHOCYTE COUNT INCREASED 9
825 MARROW HYPERPLASIA 9
826 MELAENA 9
827 MENINGITIS 9
828 MUSCLE STRAIN 9
829 MUSCLE TWITCHING 9
830 NORMOCYTIC ANAEMIA 9
831 OESOPHAGEAL CANDIDIASIS 9
832 OLIGURIA 9
833 ORAL DISORDER 9
834 PAIN IN JAW 9
835 PARANOIA 9
836 PERSONALITY CHANGE 9
837 PIGMENTATION DISORDER 9
838 PREMATURE BABY 9
839 PROTEIN TOTAL DECREASED 9
840 PSEUDOMONAL SEPSIS 9
841 PSORIATIC ARTHROPATHY 9
842 PYELONEPHRITIS 9
843 RASH PUSTULAR 9
844 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9
845 RESPIRATORY TRACT CONGESTION 9
846 RETINAL DETACHMENT 9
847 SKIN CANDIDA 9
848 SKIN HAEMORRHAGE 9
849 SKIN HYPOPIGMENTATION 9
850 SKIN TIGHTNESS 9
851 SNEEZING 9
852 STEROID DIABETES 9
853 STRONGYLOIDIASIS 9
854 SUPERINFECTION BACTERIAL 9
855 TENDON RUPTURE 9
856 THIRST 9
857 TOOTH ABSCESS 9
858 TOOTH LOSS 9
859 TRANSFUSION 9
860 TUBERCULOID LEPROSY 9
861 UPPER LIMB FRACTURE 9
862 VIRAEMIA 9
863 ABNORMAL WEIGHT GAIN 8
864 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 8
865 ADVERSE REACTION 8
866 ANGER 8
867 AUTOINFLAMMATORY DISEASE 8
868 BLOOD AMYLASE INCREASED 8
869 BLOOD LACTIC ACID INCREASED 8
870 BLOOD PRESSURE SYSTOLIC DECREASED 8
871 BLOOD TEST ABNORMAL 8
872 BONE MARROW TOXICITY 8
873 BONE MARROW TRANSPLANT 8
874 BRONCHIOLITIS 8
875 CARDIOMYOPATHY 8
876 CEREBRAL ASPERGILLOSIS 8
877 CEREBRAL INFARCTION 8
878 CLOSTRIDIAL INFECTION 8
879 COMPLICATIONS OF TRANSPLANTED KIDNEY 8
880 CONJUNCTIVITIS 8
881 CORNEAL PERFORATION 8
882 DEMENTIA 8
883 DERMATITIS ACNEIFORM 8
884 DEVICE MALFUNCTION 8
885 DISABILITY 8
886 DRUG LEVEL INCREASED 8
887 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8
888 ELECTROCARDIOGRAM QT PROLONGED 8
889 EMBOLISM 8
890 EMPHYSEMA 8
891 ERECTILE DYSFUNCTION 8
892 ESSENTIAL HYPERTENSION 8
893 EYE INFECTION 8
894 EYE MOVEMENT DISORDER 8
895 EYELID OEDEMA 8
896 FAECALOMA 8
897 FLUID IMBALANCE 8
898 FOLLICULITIS 8
899 FOREIGN BODY IN THROAT 8
900 GASTROINTESTINAL INFECTION 8
901 GOUT 8
902 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 8
903 GRAFT VERSUS HOST DISEASE IN SKIN 8
904 GRANULOMATOUS LIVER DISEASE 8
905 HAEMATEMESIS 8
906 HAEMATOTOXICITY 8
907 HAND FRACTURE 8
908 HEAD INJURY 8
909 HEMIPARESIS 8
910 HENOCH-SCHONLEIN PURPURA 8
911 HEPATITIS ACUTE 8
912 HEPATITIS TOXIC 8
913 HEREDITARY ANGIOEDEMA 8
914 HIV ASSOCIATED NEPHROPATHY 8
915 HIV INFECTION 8
916 HYPOALBUMINAEMIA 8
917 IDIOPATHIC PNEUMONIA SYNDROME 8
918 INCONTINENCE 8
919 INCREASED APPETITE 8
920 INFUSION SITE PAIN 8
921 JC VIRUS INFECTION 8
922 JOINT STIFFNESS 8
923 KAPOSI'S SARCOMA 8
924 LIBIDO DECREASED 8
925 LUNG TRANSPLANT REJECTION 8
926 LYMPHOCYTIC INFILTRATION 8
927 LYMPHOCYTOSIS 8
928 MICTURITION URGENCY 8
929 MUCOCUTANEOUS LEISHMANIASIS 8
930 MULTIPLE-DRUG RESISTANCE 8
931 MUSCULOSKELETAL CHEST PAIN 8
932 MYCOBACTERIAL INFECTION 8
933 MYCOBACTERIUM ABSCESSUS INFECTION 8
934 MYOSITIS 8
935 NEPHROPATHY 8
936 NEURITIS 8
937 NEUTROPHIL COUNT INCREASED 8
938 ONYCHOCLASIS 8
939 ORAL MUCOSAL BLISTERING 8
940 PANCREATIC DISORDER 8
941 PHARYNGOLARYNGEAL PAIN 8
942 PLASMA CELL MYELOMA RECURRENT 8
943 PLATELET TRANSFUSION 8
944 PNEUMONIA CRYPTOCOCCAL 8
945 POSTOPERATIVE WOUND INFECTION 8
946 PROCEDURAL PAIN 8
947 PRODUCT STORAGE ERROR 8
948 PULMONARY CAVITATION 8
949 RESTLESSNESS 8
950 SEASONAL ALLERGY 8
951 SECRETION DISCHARGE 8
952 SERUM AMYLOID A PROTEIN INCREASED 8
953 SKIN LACERATION 8
954 SKIN WARM 8
955 SPINAL OSTEOARTHRITIS 8
956 SUSPECTED OFF LABEL USE 8
957 SYSTEMIC CANDIDA 8
958 THERAPEUTIC PRODUCT CROSS-REACTIVITY 8
959 THERAPEUTIC RESPONSE SHORTENED 8
960 TUBERCULOSIS 8
961 URINARY TRACT INFECTION ENTEROCOCCAL 8
962 VENOOCCLUSIVE DISEASE 8
963 VIRAL LOAD INCREASED 8
964 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 7
965 AFFECTIVE DISORDER 7
966 ALANINE AMINOTRANSFERASE ABNORMAL 7
967 AMMONIA INCREASED 7
968 ANAEMIA HEINZ BODY 7
969 ANAEMIA OF CHRONIC DISEASE 7
970 ANGINA PECTORIS 7
971 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 7
972 AORTIC ANEURYSM 7
973 APHONIA 7
974 APPLICATION SITE RASH 7
975 APRAXIA 7
976 ARTHRITIS BACTERIAL 7
977 BLOOD HIV RNA INCREASED 7
978 BLOOD PHOSPHORUS DECREASED 7
979 BLOOD PRESSURE ABNORMAL 7
980 BLOOD PRESSURE DIASTOLIC ABNORMAL 7
981 BLOOD PRESSURE DIASTOLIC INCREASED 7
982 BLOOD URINE PRESENT 7
983 BODY TEMPERATURE DECREASED 7
984 CARDIOVASCULAR DISORDER 7
985 CHRONIC GASTRITIS 7
986 CHRONIC MYELOMONOCYTIC LEUKAEMIA 7
987 CYANOSIS CENTRAL 7
988 DENTAL CARIES 7
989 DEVICE ISSUE 7
990 DEVICE LEAKAGE 7
991 ELECTROLYTE IMBALANCE 7
992 ENURESIS 7
993 EOSINOPHILIC MYOCARDITIS 7
994 EXTRA DOSE ADMINISTERED 7
995 EYE HAEMORRHAGE 7
996 FEEDING DISORDER 7
997 FEELING COLD 7
998 FEELING JITTERY 7
999 FIBROSIS 7